Literature DB >> 22469412

Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

William M Hilton1, Robert S Svatek.   

Abstract

Entities:  

Year:  2012        PMID: 22469412     DOI: 10.1016/j.eururo.2012.02.011

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

Review 1.  Pharmacogenomics in bladder cancer.

Authors:  Garrett M Dancik; Dan Theodorescu
Journal:  Urol Oncol       Date:  2014-01       Impact factor: 3.498

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.